Stay updated with breaking news from Nasdaq Tsvt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2seventy bio (NASDAQ:TSVT – Get Free Report) will announce its earnings results before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.72) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. 2seventy bio (NASDAQ:TSVT – Get Free […]
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) Director Casdin Capital, Llc purchased 330,000 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were purchased at an average cost of $5.07 per share, for a total transaction of $1,673,100.00. Following the completion of the purchase, the director now directly owns […]
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) Director Casdin Capital, Llc bought 330,000 shares of the stock in a transaction dated Monday, March 25th. The shares were acquired at an average price of $5.07 per share, for a total transaction of $1,673,100.00. Following the completion of the purchase, the director now directly owns 1,960,000 […]
Clough Capital Partners L P lessened its stake in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 3.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 510,910 shares of the company’s stock after selling 18,200 shares during the quarter. Clough Capital Partners L P […]
Clough Capital Partners L P lowered its position in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 3.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 510,910 shares of the company’s stock after selling 18,200 shares during the quarter. Clough Capital Partners L P’s holdings in 2seventy bio were worth $2,003,000 at the […]